Deadline: 31-Jul-2026
The Gilead Fellowship Medical Grant Programme provides funding for not-for-profit healthcare and third sector organisations in the UK and Ireland to improve care for patients living with HIV, cancer, and liver disease. The programme supports innovative, measurable, and sustainable healthcare projects that enhance patient outcomes and strengthen healthcare systems within Gilead’s therapeutic areas.
Overview of the Programme
The Gilead Fellowship Medical Grant Programme is designed to support healthcare improvement initiatives that address major disease areas, including:
- HIV
- Cancer (Oncology)
- Liver disease
- Viral hepatitis and blood-borne viruses (BBV testing)
- CAR T therapy-related care initiatives
The programme focuses on strengthening patient care, service delivery, and community health systems.
Key Objectives
The programme aims to:
- Improve quality of life for patients with serious conditions
- Support innovative and high-impact healthcare interventions
- Strengthen healthcare delivery systems and clinical pathways
- Enhance patient support services and community care models
- Promote sustainability in healthcare programmes
- Deliver measurable health and social outcomes
- Strengthen education and awareness initiatives in healthcare
Who Can Apply? (Eligibility Criteria)
Eligible applicants include:
- Not-for-profit organisations
- Healthcare-focused institutions
- Third sector organisations
- Registered charities working in health or social care
- Organisations based in the United Kingdom or Ireland only
Key Eligibility Conditions
Applicants must:
- Operate within relevant therapeutic areas (HIV, oncology, liver disease, etc.)
- Demonstrate ability to deliver measurable patient or system-level outcomes
- Show organisational capacity to manage healthcare programmes
- Work within UK or Ireland geographic boundaries
Funding Scope and Programme Expectations
This programme supports projects that:
- Deliver measurable improvements in patient outcomes
- Strengthen healthcare system efficiency and quality
- Improve long-term care pathways for patients
- Build sustainable healthcare delivery models
- Address gaps in treatment access, education, or support services
Types of Supported Activities
- Healthcare service improvement projects
- Patient education and awareness programmes
- Community-based health interventions
- Clinical pathway optimisation
- Support service development for patients
- Training for healthcare professionals
- Sustainability and capacity-building initiatives
Application Requirements
Applicants must provide detailed project documentation, including:
Organisational Information
- Organisation contact details
- Overview of organisational mission and structure
- Relevant healthcare experience
Project Information
- Therapeutic area (HIV, oncology, liver disease, etc.)
- Project description and objectives
- Implementation plan and timeline
- Expected reach and target population
- Countries of implementation (UK or Ireland only)
- Planned activities and outcomes
Financial Information
- Total project budget
- Funding requested
- Detailed budget breakdown
- Sustainability plan
Expected Outcomes
- Patient-level improvements
- Healthcare system impact
- Community benefits
- Long-term sustainability impact
Required Supporting Documents
Applicants must submit:
- Annual report or tax documentation
- Letter of support
- New supplier form
- Signed finance department letter confirming bank details
Application Windows (2026)
The programme operates on multiple funding cycles:
- HIV Programme: 9 March – 12 June 2026
- Viral Hepatitis & BBV Testing: 1 April – 22 May 2026
- CAR T Programme: 6 April – 6 July 2026
- Oncology Programme: 5 May – 31 July 2026
Why This Programme Matters
This funding initiative plays a key role in:
- Improving care standards for chronic and life-threatening diseases
- Strengthening healthcare delivery systems in the UK and Ireland
- Supporting innovation in patient care models
- Enhancing community support structures
- Advancing sustainability in healthcare interventions
Common Mistakes to Avoid
- Submitting projects outside UK or Ireland
- Lack of measurable outcomes or impact indicators
- Weak alignment with therapeutic focus areas
- Missing required financial documentation
- Unclear sustainability planning
- Overly broad or non-specific project goals
How to Strengthen Your Application
To improve success chances:
- Clearly define measurable patient outcomes
- Align strongly with Gilead therapeutic priorities
- Provide detailed implementation timelines
- Demonstrate organisational capacity and experience
- Include strong sustainability and continuation plans
- Ensure budget transparency and justification
FAQ
1. Who can apply for this programme?
Not-for-profit healthcare and third sector organisations operating in the UK and Ireland.
2. What diseases are covered?
HIV, cancer, liver disease, viral hepatitis, BBV testing, and CAR T-related care.
3. What types of projects are funded?
Healthcare improvement, education, patient support, and service delivery initiatives.
4. Can organisations outside the UK apply?
No, only organisations operating within the UK and Ireland are eligible.
5. What is the main requirement for funding?
Projects must deliver measurable outcomes and align with Gilead’s therapeutic areas.
6. Are multiple funding cycles available?
Yes, different therapeutic areas have separate application windows in 2026.
7. What documents are required?
Financial documents, organisational information, project details, and supporting letters.
Conclusion
The Gilead Fellowship Medical Grant Programme supports targeted healthcare innovation across HIV, cancer, and liver disease care pathways in the UK and Ireland. By funding measurable, sustainable, and patient-focused initiatives, the programme strengthens healthcare systems and improves quality of life for affected communities.
For more information, visit Gilead.